Compare TTEC & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTEC | VANI |
|---|---|---|
| Founded | 1982 | 1998 |
| Country | United States | United States |
| Employees | 69400 | 36 |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.8M | 100.0M |
| IPO Year | 1996 | 2014 |
| Metric | TTEC | VANI |
|---|---|---|
| Price | $2.46 | $1.16 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | ★ 459.0K | 228.1K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,509,171,000.00 | $4,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.10 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.15 | N/A |
| 52 Week Low | $1.98 | $0.92 |
| 52 Week High | $5.59 | $1.92 |
| Indicator | TTEC | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 42.24 | 45.10 |
| Support Level | $2.12 | $1.08 |
| Resistance Level | $2.66 | $1.55 |
| Average True Range (ATR) | 0.20 | 0.06 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 16.00 | 18.07 |
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through two operating segment, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its revenues are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.